<p>The invention features methods for selecting an HIV treatment regimen for HIV positive subjects. Such regimens include the administration of CD59 inhibitors including ?LY domain 4. CD59 activity is associated with a decreased sensitivity to endogenous and exogenous anti-HIV antibodies. Desirably, administration of ILY domain 4 polypeptides is sufficient to inhibit CD59 activity while avoiding the general toxicity associated with full length ILY.</p>
申请公布号
WO2010078331(A1)
申请公布日期
2010.07.08
申请号
WO2009US69694
申请日期
2009.12.29
申请人
PRESIDENT AND FELLOWS OF HARVARD COLLEGE;QIN, XUEBIN;HU, WEIGUO;HALPERIN, JOSE, A.